Katharine Ellwood‐Yen

Author

University of California, Los Angeles

Also Known As

Katharine Ellwood-Yen, Katharine Ellwood‐Yen

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Memorial Sloan Kettering Cancer Center Howard Hughes Medical Institute Merck & Co., Inc., Rahway, NJ, USA (United States)Vanderbilt University Medical Center

About

Katharine Ellwood‐Yen is an author at University of California, Los Angeles specializing in tumor biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.1K
2	Cell Biology	4	4	1.1K
3	Tumor Biology	4	4	1.1K
4	Cell Signaling	1	1	32
5	Systems Biology	1	1	32

Katharine Ellwood‐Yen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Myc-driven murine prostate cancer shares molecular features with human prostate tumors Katharine Ellwood‐Yen, Thomas G. Graeber, John Wongvipat, Cancer Cell UrologyMedicineHuman Prostate TumorsCancer GenomicsProstatic Disease	2003	805
BCR-ABL point mutants isolated from patients with imatinib mesylate–resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90 M. Gorre, Katharine Ellwood‐Yen, Gabriela Chiosis, Blood	2002	278
The Nuclear Factor-κB Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth Ren Jie Jin, Yongsoo Lho, Linda Connelly, Cancer Research	2008	176
A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression Pradip K. Majumder, Chiara Grisanzio, Fionnuala O’Connell, Cancer Cell UrologyGenitourinary CancerMedicineCancer ProgressionInhibits Cell Proliferation	2008	169
Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell Line Philip A. Watson, Katharine Ellwood‐Yen, Jennifer C. King, Cancer Research	2005	162
MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors Nicola J. Clegg, Suzana S. Couto, John Wongvipat, PLoS ONE UrologyGenitourinary CancerAlters SensitivityMedicineProstate Tumorigenesis	2011	88
Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model Srinivas Nandana, Katharine Ellwood‐Yen, Charles L. Sawyers, The Prostate	2009	40
Transgenic Mouse Model for Rapid Pharmacodynamic Evaluation of Antiandrogens Katharine Ellwood‐Yen, John Wongvipat, Charles L. Sawyers Cancer Research	2006	36
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models Katharine Ellwood‐Yen, Heike Keilhack, Kaiko Kunii, Cancer Research Cancer ResearchSignaling PathwayMtor InhibitorsCell RegulationMedicine	2011	32

Page 1